コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 despite reduced diastolic pressure and total peripheral resistance.
2 ystem, and increased vascular tone and total peripheral resistance.
3 rterial enlargement in response to increased peripheral resistance.
4 lity, systemic compliance, stroke volume and peripheral resistance.
5 ormal, where it is quickly reflected off the peripheral resistance.
6 cant increases in SS RBC adhesion and in the peripheral resistance.
7 sure, occurs as the consequence of increased peripheral resistance.
8 ke volume, possibly as a result of decreased peripheral resistance.
9 ut (5.5 vs. 4.9 l/min; P < 0.001), and lower peripheral resistance (1,487 vs. 1,666; P = 0.01), paral
10 15% vs. -5 +/- 10%), and a lower decrease in peripheral resistance (-17 +/- 12% vs. -26 +/- 12%) (p <
11 n increase in blood pressure (43%) and total peripheral resistance (65%) without any change in heart
14 on were hypotensive, with decreases in total peripheral resistance and filtration fraction on day 1 i
15 rolled for, hypertensive subjects had higher peripheral resistance and lower arterial compliance than
19 during EFP than MLP (P = 0.030), while total peripheral resistance and plasma noradrenaline were not
20 nts present with low cardiac output and high peripheral resistance and that they respond poorly to fl
21 pressure and is a fundamental determinant of peripheral resistance and, hence, organ perfusion and sy
22 high rate of LV hypertrophy, in spite of low peripheral resistances and low-to-normal blood pressure,
24 stemic oxygen delivery, stroke volume, total peripheral resistance, and organ blood flow in the liver
25 ate, preload, and cardiac output; decreasing peripheral resistance; and increasing ventricular compli
26 ecause endothelial dysfunction and increased peripheral resistance are hallmarks of hypertension, det
28 ar volumes and end-systolic elastance (Ees), peripheral resistance, arterial elastance (Ea), arterial
31 f altered arterial stiffness versus impaired peripheral resistance but is not superior to SBP+DBP in
32 ut and decreases in left atrial pressure and peripheral resistance but without eliciting a supplement
33 sure, portal pressure, cardiac output, total peripheral resistance, central blood volume, and extrace
34 er (P = 0.09), heart rate was similar, total peripheral resistance decreased (2172 +/- 364 vs. 2543 +
35 nfusion before any symptoms developed, total peripheral resistance decreased 24% +/- 20% in group II
36 to tilt before any symptoms developed, total peripheral resistance decreased 9% +/- 14% in group I fr
39 s include increased cardiac work with normal peripheral resistance, diffuse slowing on electroencepha
42 tput, and calculated stroke volume and total peripheral resistance, during supine rest and 10 min of
43 ined by LV end-diastolic dimension and total peripheral resistance estimated by thoracic impedance.
44 to 86.9 +/- 21.7 ml (P = 0.06) and increased peripheral resistance from 1106 +/- 246 to 1246 +/- 222
47 In vivo, human U-II markedly increases total peripheral resistance in anaesthetized non-human primate
52 ntry communication) and physiologic factors (peripheral resistance in the branch vessels, pump output
57 nd 1.15 versus 1.02 mm Hg/mL x m2) and total peripheral resistance index (3027 and 2805 versus 2566 d
58 n cardiac index, a 28% increase in the total peripheral resistance index (p < .01), and a 33% decreas
63 mean arterial pressure of 18 mm Hg and total peripheral resistance of 665 AU and increases in heart r
66 decreases in left atrial pressure (P<0.001), peripheral resistance (P=0.014), and hematocrit (P<0.001
69 epsis), cardiac output, stroke volume, total peripheral resistance, systemic oxygen delivery, and org
70 oth muscle cells of a primary determinant of peripheral resistance - the small mesenteric artery.
72 cially the visceral type, is associated with peripheral resistance to insulin actions and hyperinsuli
73 modalities, such as exercise, may overcome a peripheral resistance to insulin, thus preventing GDM or
75 ng leptin and have the potential to induce a peripheral resistance to leptin, similar to the central
76 roke volume (SV), cardiac output (CO), total peripheral resistance (TPR) and arterial compliance to a
77 tivity (MSNA) is positively related to total peripheral resistance (TPR) and inversely related to car
78 asures of preejection period (PEP) and total peripheral resistance (TPR) in healthy black (n=76) and
79 ed, whereas heart rate (HR), MSNA, and total peripheral resistance (TPR) increased during HUT (all P<
81 decrease in cardiac contractility and total peripheral resistance (TPR) were similar in TRPV(1)(+/+)
84 d action of nitric oxide and endothelin-1 in peripheral resistance vessels of patients with syndrome
86 2 +/- 0.40 l min(-1), P = 0.01), while total peripheral resistance was greater (1327 +/- 117 vs. 903
88 ght with CFD than in those with PFD, whereas peripheral resistance was not significantly different.
89 volume (r=0.88+/-0.13, P<0.05), while total peripheral resistance was related to MSNA during 45 min
92 eart rate, mean arterial pressure, and total peripheral resistance were greater, whereas cardiac outp
95 decrease in diastolic pressure and estimated peripheral resistance were observed in troglitazone-trea
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。